Proteolysis of the matricellular protein hevin by matrix metalloproteinase‐3 produces a SPARC‐like fragment (SLF) associated with neovasculature in a murine glioma model

Abstract

The matricellular SPARC‐family member hevin (Sparc‐like 1/SPARCL‐1/SC1/Mast9) contributes to neural development and alters tumor progression in a range of mammalian models. Based on sequence similarity, we hypothesized that proteolytic digestion of hevin would result in SPARC‐like fragments (SLF) that affect the activity and/or location of these proteins. Incubation of hevin with matrix metalloproteinase‐3 (MMP‐3), a protease known to cleave SPARC, produced a limited number of peptides. Sequencing revealed the major proteolytic products to be SPARC‐like in primary structure. In gliomas implanted into murine brain, a SLF was associated with SPARC in the neovasculature but not with hevin, the latter prominent in the astrocytes encompassed by infiltrating tumor. In this model of invasive glioma that involves MMP‐3 activity, host‐derived SLF was not observed in the extracellular matrix adjacent to tumor cells. In contrast, it occurred with its homolog SPARC in the angiogenic response to the tumor. We conclude that MMP‐3‐derived SLF is a marker of neovessels in glioma, where it could influence the activity of SPARC. J. Cell. Biochem. 112: 3093–3102, 2011.